Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, announced that enrollment is complete in the pivotal Phase 3 RECOVER study evaluating brilaroxazine for schizophrenia, with 402 patients enrolled at multiple sites in the United States (~60%), Europe (~10%), and Asia (~30%).

60 Degrees Pharmaceuticals, Inc. (“60P”) (NASDAQ: SXTP), a company specializing in developing and marketing medicines for infectious diseases, today announced that ACLR8-LR, a double-blind, randomized, placebo-controlled Phase IIB study to determine the efficacy of the ARAKODA® regimen of tafenoquine in COVID-19 patients with mild-moderate symptoms and low risk of disease progression, is now listed on ClinicalTrials.gov. The trial will be conducted by 60P’s majority-owned subsidiary, 60P Australia Pty Ltd, which opened a new IND on August 14, 2023.

Splash Beverage (NYSE American: SBEV), a portfolio company of leading beverage brands, reported financial results for the second quarter period ended June 30, 2023. Robert Nistico, Splash Beverage Group’s Chairman and CEO, commented, “Our 2023 second quarter results reflect the strengths that we are developing as we grow the business as well as some of the challenges that inevitably emerge in growth businesses. Our Qplash platform, which has increased 43% in the first half of the year compared to last year, is developing very nicely on both a B2B and B2C basis and is now expanding to select international markets.”

Rail Vision Ltd. (Nasdaq: RVSN) (“Rail Vision” or the “Company”), a development stage technology company seeking to revolutionize railway safety and the data-related market, reported financial results for the second quarter ended June 30, 2023. "We continued to strengthen our foundation during the second quarter, completing a series of transactions that raised gross proceeds of $6 million, including an additional investment by our largest shareholder, Knorr-Bremse,” commented Shahar Hania, CEO of Rail Vision. “In addition to fortifying our balance sheet, these transactions lay a robust base for accelerated growth as are growing number of proof-of-concept customers transition to larger purchase orders and contracts.”